Fri, May 3, 2024

Chris Shibutani Maintained (UTHR) at Hold with Increased Target to $240 on, May 3rd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-240-on-may-3rd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Chris Shibutani of Goldman Sachs, Maintained "United Therapeutics Corporation" (UTHR) at Hold with Increased Target from $218 to $240 on, May 3rd, 2024.

Chris has made no other calls on UTHR in the last 4 months.



There are 5 other peers that have a rating on UTHR. Out of the 5 peers that are also analyzing UTHR, 0 agree with Chris's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Chris


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 2nd, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Thursday, May 2nd, 2024
  • Tiago Fauth of "Wells Fargo" Maintained at Buy with Increased Target to $325 on, Thursday, March 7th, 2024
  • Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $308 on, Thursday, February 22nd, 2024
  • Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $330 on, Monday, February 5th, 2024

Publication Contributing Sources